2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EREG11
Submitter : Mrs. Carolyn M. Gilman Date & Time: 09/28/2005 05:09:58
Organization : State of Maine
Category : State Government
Issue Areas/Comments
As a member of the 121st legislature, the Maine Senate, I did extensive research on the "morning after pill" and found much evidence of the danger of this pill to teens and all wormen in general. Often this pill is an abortifcient with many risks and danger of death. I am very much against allowing this pill without a prescription to our teens.